The global Real-time PCR (qPCR) and Digital PCR (dPCR) market size was estimated at USD 3.0 billion in 2016. High demand for rapid diagnostics tests and implementation of the Minimum Information for Publication of qPCR Experiments (MIQE) guidelines are expected to be the high impact rendering drivers for market growth.
Prevalence of chronic diseases, infectious diseases, and genetic disorders such as cancer, hepatitis B, and HIV has increased at a steep rate, which is expected to propel the market growth. According to the World Health Organization (WHO), cancer is the second leading cause of death and was responsible for 8.8 billion deaths globally in 2015. The WHO estimates that nearly 257 billion people are living with Hepatitis B infection. Around 36.7 million were living with HIV at the end of 2015.
U.S. qPCR and dPCR market size, by technology, 2014 - 2025 (USD Million)
Continuous introduction of technologically advanced devices is expected to increase the usage. However, an increasing demand for rare event detection and variation analysis from researchers has led to the increased adoption of advanced devices such as QX100 Droplet Digital PCR (ddPCR) system developed by Bio-Rad Laboratories.
Implementation of MIQE and RDML guidelines is anticipated to significantly impact the global market. These guidelines allow standardization of experimental data and highly reliable interpretation of qPCR results, and encourage experimental transparency. All the aforementioned factors are expected to drive the growth of the market.
In addition, wide applications of qPCR and dPCR technology is estimated to increase the adoption rate. qPCR has diverse applications in various research areas such as oncology, genetic diseases, stem cells, pathogen detection, infectious diseases, pharmacogenomics, pharmaceutical analytics, and plant sciences.
On the basis of technology, the market is categorized into quantitative and digital. The quantitative PCR segment in terms of value accounted for the largest share in 2016. High usage in gene expression analysis and genotyping as a validation tool and increased adoption rate are expected to drive the growth of the segment.
dPCR is anticipated to witness highest growth in the near future owing to its advantages in research and other applications, such as detecting and quantifying low frequency mutations & low levels of pathogens with increased sensitivity.Automation of these processes is an additional advantage.In addition, digital devices offer higher sensitivity and resolution, enabling the researchers to check minor differences and quantify them accurately in the wild-type sequence.
Based on product, the market is categorized into consumables & reagents, instruments, and software & services. The consumables and reagents segment dominated the overall market in terms of revenue in 2016, owing to their increasing adoption.
Consumables and reagents influence the performance of the overall assay. They help create standardized workflow to support researchers in areas such as food testing, detection of cancer & infectious diseases, and forensics. The above aforementioned factors are factors contributing toward dominance of this segment.
Based on application, the market is categorized into clinical, research, forensic, and others. Application of these devices in research was highest in 2016. Wide applications of qPCR and dPCR in research, commercialization of new dPCR instruments such as droplet dPCR, QuantStudio 3D dPCR, and BioMark HD dPCR system are expected to propel growth.
On the other hand, the clinical application segment is expected to witness fastest growth over the forecast period owing to increasing adoption of these techniques in diagnostic centers & hospitals and growing base of target population.
North America dominated the regional segment with the largest share of revenue in 2016 followed by Europe. Key factors contributing toward the dominance are increase in investments for gene-based research, rising private & public funding support, and product advancements in the field of qPCR such as QuantStudio 5 real-time PCR system used for human identification in forensic laboratories.
Global qPCR and dPCR market share, by region, 2016 (%)
However, Asia Pacific is expected to grow at a lucrative CAGR over the forecast period due to growing healthcare expenditure, presence of huge target population base, increasing adoption of qPCR technology, and public & private support to develop novel technologies in this field. Asia Pacific is projected to grow at a significant CAGR of 10.8 % over the forecast period.
Some of the key players dominating the qPCR and dPCR market are Thermo Fisher Scientific Inc.; Bio-Rad Laboratories, Inc.; QIAGEN, Abbott; Cepheid, Agilent Technologies; GE Healthcare; bioMérieux SA; F. Hoffmann-La Roche Ltd; and Fluidigm Corporation.
qPCR and dPCR products are widely used in the detection of disease and clinical & research applications. For instance, F. Hoffmann-La Roche Ltd.’s cobas HEV test is used for detecting hepatitis E virus. Key players focus on technological advancements, partnerships, and collaborations to maintain their position in the industry. On March 15, 2017, Thermo Fisher Scientific Inc., launched the QuantStudio 5 Real-Time PCR system for human identification useful in modern forensic laboratories.
|
Attribute |
Details |
|
Base year for estimation |
2016 |
|
Actual estimates/Historical data |
2014 - 2016 |
|
Forecast period |
2017 - 2025 |
|
Market representation |
Revenue in USD Million and CAGR from 2017 to 2025 |
|
Regional scope |
North America, Europe, Asia Pacific, Latin America, Middle East & Africa |
|
Country scope |
U.S., Canada, Germany, UK, China, India, Japan, Brazil, Mexico, South Africa |
|
Report coverage |
Revenue forecast, company share, competitive landscape, growth factors and trends |
|
15% free customization scope (equivalent to 5 analyst working days) |
If you need specific market information, which is not currently within the scope of the report, we will provide it to you as a part of customization |
This report forecasts revenue growth at global, regional & country levels and provides an analysis on the industry trends in each of the sub-segments from 2016 to 2025. For the purpose of this study, Grand View Research has segmented the global qPCR and dPCR market on the basis of technology, product, application and region:
Technology Outlook (Market Revenue in USD Million, 2014 - 2025)
Quantitative
Digital
Product Outlook (Market Revenue in USD Million, 2014 - 2025)
Consumables & Reagents
Instruments
Software & Services
Application Outlook (Market Revenue in USD Million, 2014 - 2025)
Clinical
Pathogen Testing
Blood Screening
Oncology Testing
Others
Research
Forensic and others
Regional Outlook (Revenue, USD Million, 2014 - 2025)
North America
U.S.
Canada
Europe
Germany
UK
Asia Pacific
China
Japan
India
Latin America
Brazil
Mexico
Middle East & Africa
South Africa
Avail customized purchase options to meet your exact research needs:
Get your queries resolved from an industry expert.
Design an exclusive study to serve your research needs.
A testimonial for service in the form of BBB "A" Accreditation.
Your personal and confidential information is safe and secure.
"The quality of research they have done for us has been excellent..."
